Sulphonamides: n.e.c. in heading no. 2935

In 2024, sulphonamides: n.e.c. in heading no. 2935 trade exhibited modest growth, with global flows reaching $8,698,804,848 and a three-year compound annual growth rate of -5.8% (five-year: -3.9%). The all-time peak of $10,982,043,804 was recorded in 2018; the current level is 21% below that high-water mark.

Over the 30-year observation window (1995–2024), 66% of years recorded positive growth, indicating a predominantly expanding market. Trend momentum is decelerating (-6.8% acceleration).

The supply side is moderately concentrated (Herfindahl-Hirschman Index 0.212). The three largest exporters — Switzerland ($3.0B), Ireland ($2.5B), and China ($668.9M) — collectively dominate supply flows. The leading exporter has grown at +14.5% over the last three years.

On the demand side, importer concentration is diversified (HHI 0.117). The three largest import markets are United States ($1.9B), Slovenia ($1.6B), and Spain ($1.1B). The largest importing market sources from 36 different supplying countries.

The dominant trade corridor is Switzerland → Slovenia at $1.6B, representing 98.7% of the importer's total demand.

The volatility score for sulphonamides: n.e.c. in heading no. 2935 is 5 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, modest but steady demand provides a reasonable entry window. A moderately concentrated market rewards differentiated positioning and strategic partner selection.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.